Transforming Patients' Lives
Gianni Garotta, Member, Board of Directors
Gianni Garotta, PhD, has a combined record of academia, pharmaceutical and biotech experience. He founded three biotech companies and was most recently executive advisor for the italian incubator Eporgen Venture. Prior to this, Dr. Garotta was VP Academic Collaborations and Extramural Research at Serono, head of biology at Human Genome Sciences as well as head of both the interferon and the antibody groups at Hoffmann la Roche.
His achievements include the preclinical and phase I development of the first drug discovered by the genomic approach and the development of a further three drugs in phase I-II.
Dr. Garotta has a strong background in drug discovery and development as well as experience in identifying, evaluating and negotiating the transfer of assets from academia and in managing outsourced research programs.
Dr. Garotta graduated with a degree in biology from the University of Milan. He then completed a PhD in Physiology at the University of Milan and worked at the Wistar Institute of Philadelphia, at the Istituto Nazionale per lo Studio e la Cura dei Tumori di Milano and at the Basel Institute of Immunology.
OncoNOx ApS - Ole Maaløes Vej 3 - 2200 Copenhagen - Denmark